Tuesday, November 18, 2014
Print Current Session:
|
|
Tuesday
SESSION 11:
MORE LOWER EXTREMITY HOT TOPICS – NEW STENT AND DRUG ELUTING BALLOON (DEB) DATA; IMPACT AND COST ISSUES
Moderators:Joseph L. Mills, MD / Giancarlo Biamino, MD, PhD
|
|
SESSION 11 SCHEDULE | |
8:38 AM - 8:43 AM | Is There A Negative Effect Of Endovascular Failure On Bypass Outcomes: Is It Reality Or A Myth |
Presenter(s):Michael S. Conte, MD | |
View Abstract | |
8:44 AM - 8:49 AM | What Is The Effect Of Extensive Lesion Calcification On The Outcome Of DEB Treatment |
Presenter(s):Gunnar Tepe, MD | |
View Abstract | |
8:50 AM - 8:55 AM | Why Are DEBs Cost Effective For Treating CLI Patients |
Presenter(s):Thomas Zeller, MD | |
View Abstract | |
8:56 AM - 9:01 AM | How To Align Financial Incentives For The Doctor, The Hospital And The Payer (Insurance Company) To Provide The Best And Most Effective Care In The Least Costly Manner: Impact Of Expensive New Technologies And Reintervention Rates |
Presenter(s):W. Charles Sternbergh III, MD | |
View Abstract | |
9:02 AM - 9:07 AM | Tips And Tricks For Tibial Interventions For CLI |
Presenter(s):Roberto Ferraresi, MD | |
View Abstract | |
9:08 AM - 9:13 AM | What’s New With US Approved Drug Eluting Stents (DESs) In The SFA And Below |
Presenter(s):Ron Waksman, MD | |
View Abstract | |
9:14 AM - 9:19 AM | 5-Year Results And New Findings From The Zilver PTX RCT And Registry: Benefits Of DESs Are Durable And Value With In Stent Restenosis (ISR), Long Lesions And Diabetics |
Presenter(s):Michael D. Dake, MD | |
View Abstract | |
9:20 AM - 9:25 AM | 2-3-Year Results With EverFlex Helical Nitinol Stent In The SFA And The Popliteal Artery: Are The Benefits Durable |
Presenter(s):Marc Bosiers, MD / Patrick Peeters, MD | |
View Abstract | |
9:25 AM - 9:33 AM | Panel Discussion |
9:33 AM - 9:48 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 11 | |
previous | next |